Business Context and Reporting Period
This Form 8-K Current Report was filed by AtriCure, Inc. on April 8, 2021. The filing primarily addresses corporate governance changes regarding the Board of Directors effective at the 2021 Annual Meeting of Stockholders scheduled for May 20, 2021.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
The following material changes to the Board of Directors were announced:
- Election of Board Chair: B. Kristine Johnson has been elected to serve as Board Chair, effective as of the 2021 Annual Meeting.
- Departure of Directors: Scott W. Drake and Mark R. Lanning will not stand for reelection to the Board at the Annual Meeting.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on business outlook, or specific risk factors. The document serves as a notification of the attached press release (Exhibit 99.1) detailing the Board composition changes.
Key Facts for Investor Verification
- Verify the exact date of the 2021 Annual Meeting of Stockholders (scheduled for May 20, 2021) to confirm the effective date of the Board Chair election.
- Review the attached press release (Exhibit 99.1) for detailed biographies of the new Chair and the reasons for the departing directors' decision not to seek reelection.
- Confirm the updated Board composition in subsequent proxy statements or corporate filings.